Follow the 通化金马 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 通化金马 has recorded 2 insider filings. Market capitalisation: €16.5bn. The latest transaction was filed on 2 July 2026 (Purchase). Among the most active insiders: 张玉富. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Tonghua Golden Horse is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of pharmaceuticals.